Artak Khachatryan is Sr. Director, Pharmacoepidemiology in Analytica Laser, Certara’s Evidence and Access Group. Artak joined Analytica Laser in 2010 to participate in the conduct of the International Study of Insulin & Cancer, for the UK. He then directed an international observational study on the relative effectiveness of atrial fibrillation treatments, recruiting in Germany, USA, Spain & Italy.
He is the senior epidemiologist on several projects, including an international cohort study on the relative effectiveness of intensive therapies in diabetes, conducted in the UK, Spain, Belgium and France. Artak is a qualified general surgeon. He completed his PhD in Epidemiology at University College of London.